Biosimilars are taking on the multi-billion-dollar blockbuster drugs of today, with some sources suggesting that the market will be worth greater than $20 billion per annum within the next couple of years. The growth is being driven by factors such as healthcare systems looking to reduce costs and the growing…
It took 13 years and £2 billion to sequence the human genome back in 2003. Fast forward 15 years to today and next-generation sequencing (NGS) can do it for less than $1,000 in a matter of days. High-throughput sequencing technologies, computational power and data-mining techniques have opened up a whole…
Diagnostic testing is rapidly moving out of the lab and into the hands of untrained users. But developing the system architecture for a high-performance test that is also easy to use is a complex challenge.A great example of advancements in point-of-care (PoC) testing is the pregnancy test. In the 1970s,…
Innovative technology and design consultancy Cambridge Design Partnership today announces that it has developed the world’s first wearable device designed to measure and monitor the vital signs of multiple trauma patients for emergency response in disasters and battlefield situations. The First Response Monitor is designed to help medics monitor both…